Assessing the Performance of Extended Half-Life Coagulation Factor VIII, FC Fusion Protein by Using Chromogenic and One-Stage Assays in Saudi Hemophilia A Patients
Background. The one-stage assay is the most common method to measure factor VIII activity (FVIII : C) in hemophilia A patients. The chromogenic assay is another two-stage test involving purified coagulation factors followed by factor Xa-specific chromogenic substrate. Aim. This study aimed to assess...
Main Authors: | Tarek M. Owaidah, Hazzaa A. Alzahrani, Nouf S. Al-Numair, Abdulmjeed O. Alnosair, Amelita M. Aguilos, Mahasen Saleh |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2020/8768074 |
Similar Items
-
Therapeutic and routine prophylactic properties of rFactor VIII Fc (efraloctocog alfa, Eloctate®) in hemophilia A
by: Chowdary P, et al.
Published: (2016-09-01) -
Potentiation of thrombin generation in hemophilia A plasma by coagulation factor VIII and characterization of antibody-specific inhibition.
by: Bhavya S Doshi, et al.
Published: (2012-01-01) -
Prevalence of Coagulation Factors Deficiency among Young Adults in Saudi Arabia: A National Survey
by: Khalid A. AlSaleh, et al.
Published: (2020-10-01) -
Extended half‐life factor VIII concentrates in adults with hemophilia A: Comparative pharmacokinetics of two products
by: Jerome Teitel, et al.
Published: (2021-02-01) -
Spectrophotometric Determination of Os(VIII) with Nitroso R Salt as Chromogenic Reagent
by: Rodica WENKERT, et al.
Published: (2011-09-01)